MiMedx Group Inc
NASDAQ:MDXG
MiMedx Group Inc
NASDAQ:MDXG
Price:
7.15 USD
0.42%
Market Closed
Updated:
Jun 1, 2024
MiMedx Group Inc
Additional Paid In Capital
|
MiMedx Group Inc
Additional Paid In Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
MiMedx Group Inc
NASDAQ:MDXG
|
Additional Paid In Capital
$280m
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Additional Paid In Capital
$6.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
22%
|
CAGR 10-Years
2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Additional Paid In Capital
$7.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Additional Paid In Capital
$11.9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
23%
|
CAGR 10-Years
18%
|
See Also
What is MiMedx Group Inc's Additional Paid In Capital?
Additional Paid In Capital
280m
USD
280m
USD
Based on the financial report for Mar 31, 2024, MiMedx Group Inc's Additional Paid In Capital amounts to 280m USD.
What is MiMedx Group Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
6%
6%
Over the last year, the Additional Paid In Capital growth was 57%. The average annual Additional Paid In Capital growth rates for MiMedx Group Inc have been 21% over the past three years , 11% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
